Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1942-1961
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1942
Figure 8 Immunohistochemical results of retinal tissue from different rat models.
A: Immunohistochemical detection of Caspase-3; B: Immunohistochemical detection of c-Jun; C: Immunohistochemical detection of MAPK1; D: Immunohistochemical detection of MAPK3 positive expression (200 ×). The sequence from left to right represents the control group, the model group, the Buqing granule group and the calcium dobesilate group. aP < 0.05, bP < 0.01, cP < 0.001. BQKL: Buqing granule; CaD: Calcium dobesilate.
- Citation: Yang YF, Yuan L, Li XY, Liu Q, Jiang WJ, Jiao TQ, Li JQ, Ye MY, Niu Y, Nan Y. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World J Diabetes 2024; 15(9): 1942-1961
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1942.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1942